BridgeBio has significantly improved the progress of an new therapy for cardiac amyloidosis, employing the compound. Initial clinical results suggests potential improvements for patients diagnosed by the debilitating https://attr-cm977674.fireblogz.com/73722165/company-advances-amyloidosis-treatment-with-the-therapy